Examples of using Advanced phase in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
In the study of advanced phase CML and Ph+ALL, the primary endpoint was MaHR.
Table 8 Efficacy of Iclusig in resistant or intolerant advanced phase CML patients.
Advanced Phase CML and Ph+ALL 140 mg once daily 70 mg twice daily n 304 n 305 All Grades Grade 3/ 4 All Grades Grade 3/ 4.
4 haemorrhage occurred in 2% of patients with advanced phase CML.
In 1,094 patients with advanced phase CML or Ph+ ALL, the median duration of treatment for
Table 3- Efficacy results in previously treated patients with chronic and advanced phase CML.
Their occurrence is more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML.
intolerant patients with advanced phase CML and Ph+ALL.
more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML see section 4.4.
are applicable to patients with Parkinson's disease in a more advanced phase.
In adult patients, Imatinib Actavis is intended for use in the most advanced phase of the disease blast crisis.
In the study of patients with advanced phase CML or Ph+ ALL, the response in terms of blood counts was also similar with once-
Incidence in the four treatment groups; elevations were reported in 1% to 4% of patients with advanced phase CML and Ph+ALL.
Their occurrence is more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML see section 4.4.
Table 3b: Selected adverse reactions reported in phase III dose-optimisation study: Advanced phase CML and Ph+ ALLa.
In patients with advanced phase CML or Ph+ ALL, complete blood counts should be performed weekly for the first 2 months,
Table 10: Efficacy of SPRYCEL in phase III dose-optimisation study: advanced phase CML and Ph+ ALL(2 year results)a.
In clinical studies in patients with advanced phase CML receiving the recommended dose of SPRYCEL(n=304),
See section 4.4 for further information on patients with chronic phase CML and advanced phase CML or Ph+ ALL.
For patients with advanced phase CML or Ph+ ALL who received 140 mg once daily, dose reduction to 100 mg once daily with further reduction from 100 mg once daily to 50 mg once daily, if needed, is recommended.
the other in 611 patients with advanced phase CML or Ph+ ALL.
Won't you join me as a standard bearer in this, the advanced phase of expression and learning on planet Earth,
more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML.
were reported with an increased frequency of 1 to 4% of patients with advanced phase CML.
The dose of 340 mg/m2 daily is recommended for children with chronic phase CML and advanced phase CML not to exceed the total dose of 800 mg.
In clinical studies in patients with advanced phase CML receiving SPRYCEL at the recommended dose(n=304),
Grade 3 or 4 gastrointestinal haemorrhage occurred in 6% of patients with advanced phase CML and generally required treatment interruptions and transfusions.
elevations were reported with an increased frequency of 1 to 7% of patients with advanced phase CML and Ph+ ALL.
180 mg once daily(advanced phase CML or Ph+ ALL)
In the Phase III dose-optimisation study in patients with advanced phase CML and Ph+ ALL,